Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Julphar
Daiichi Sankyo
Chubb
QuintilesIMS

Generated: March 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR JAKAFI

« Back to Dashboard

Clinical Trials for Jakafi

Trial ID Title Status Sponsor Phase Summary
NCT01251965 Phase l/II Study of Ruxolitinib for Acute Leukemia Completed Incyte Corporation Phase 1/Phase 2 The goal of this clinical research study is to find the highest tolerable dose of ruxolitinib that can be given to patients with acute leukemia and to learn if the study drug can help control the disease. The safety of the drug will also be studied.
NCT01251965 Phase l/II Study of Ruxolitinib for Acute Leukemia Completed M.D. Anderson Cancer Center Phase 1/Phase 2 The goal of this clinical research study is to find the highest tolerable dose of ruxolitinib that can be given to patients with acute leukemia and to learn if the study drug can help control the disease. The safety of the drug will also be studied.
NCT01732445 Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis Active, not recruiting National Cancer Institute (NCI) Phase 2 This phase II pilot trial studies how well ruxolitinib phosphate and danazol work in treating anemia in patients with myelofibrosis. Ruxolitinib phosphate and danazol may cause the body to make more red blood cells. They are used to treat anemia in patients with myelofibrosis.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Jakafi

Condition Name

Condition Name for Jakafi
Intervention Trials
Leukemia 8
Myelofibrosis 5
Secondary Myelofibrosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Jakafi
Intervention Trials
Leukemia 11
Primary Myelofibrosis 9
Leukemia, Lymphoid 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Jakafi

Trials by Country

Trials by Country for Jakafi
Location Trials
United States 66
China 3
Canada 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Jakafi
Location Trials
Texas 12
Arizona 7
New York 5
Massachusetts 5
California 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Jakafi

Clinical Trial Phase

Clinical Trial Phase for Jakafi
Clinical Trial Phase Trials
Phase 2 19
Phase 1/Phase 2 8
Phase 1 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Jakafi
Clinical Trial Phase Trials
Recruiting 21
Not yet recruiting 10
Active, not recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Jakafi

Sponsor Name

Sponsor Name for Jakafi
Sponsor Trials
Incyte Corporation 19
M.D. Anderson Cancer Center 10
National Cancer Institute (NCI) 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Jakafi
Sponsor Trials
Other 33
Industry 26
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Argus Health
AstraZeneca
US Army
Daiichi Sankyo
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.